Redeye: CombinedX - Splitting Aspire
Redeye takes a positive stance towards the partial divestment of Aspire. While it puts some question marks on the 2022 acquisition of Attentec, we believe the move is financially and strategically wise.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/